Related Experiment Video
Updated: Jun 13, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
The tyrosine phosphatase Shp2 in development and cancer
Katja S Grossmann1, Marta Rosário, Carmen Birchmeier
1Department of Cancer Research, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.
Abstract:
Deregulation of signaling pathways, through mutation or other molecular changes, can ultimately result in disease. The tyrosine phosphatase Shp2 has emerged as a major regulator of receptor tyrosine kinase (RTK) and cytokine receptor signaling. In the last decade, germline mutations in the human PTPN11 gene, encoding Shp2, were linked to Noonan (NS) and LEOPARD syndromes, two multisymptomatic developmental disorders that are characterized by short stature, craniofacial defects, cardiac defects, and mental retardation. Somatic Shp2 mutations are also associated with several types of human malignancies, such as the most common juvenile leukemia, juvenile myelomonocytic leukemia (JMML). Whereas NS and JMML are caused by gain-of-function (GOF) mutations of Shp2, loss-of-function (LOF) mutations are thought to be associated with LEOPARD syndrome. Animal models that carry conditional LOF and GOF mutations have allowed a better understanding of the mechanism of Shp2 function in disease, and shed light on the role of Shp2 in signaling pathways that control decisive events during embryonic development or during cellular transformation/tumorigenesis.
Insights
Shp2 tyrosine phosphatase mutations cause developmental disorders like Noonan syndrome and cancers such as juvenile myelomonocytic leukemia. Understanding Shp2's role in signaling pathways is key to disease mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Shp2 tyrosine phosphatase regulates receptor tyrosine kinase (RTK) and cytokine receptor signaling.
- Germline mutations in the PTPN11 gene (encoding Shp2) are linked to Noonan (NS) and LEOPARD syndromes.
- Somatic Shp2 mutations are implicated in human malignancies, including juvenile myelomonocytic leukemia (JMML).
Purpose of the Study:
- To elucidate the role of Shp2 in signaling pathways.
- To understand the mechanisms of Shp2 in embryonic development and tumorigenesis.
- To investigate the link between Shp2 mutations and human diseases.
Main Methods:
- Analysis of germline and somatic mutations in the PTPN11 gene.
- Utilizing animal models with conditional gain-of-function (GOF) and loss-of-function (LOF) Shp2 mutations.
- Studying Shp2's function in receptor tyrosine kinase and cytokine receptor signaling pathways.
Main Results:
- Gain-of-function (GOF) Shp2 mutations cause Noonan syndrome and JMML.
- Loss-of-function (LOF) Shp2 mutations are associated with LEOPARD syndrome.
- Animal models demonstrate Shp2's critical role in embryonic development and cellular transformation.
Conclusions:
- Shp2 is a crucial regulator of signaling pathways involved in development and cancer.
- Understanding Shp2's function is vital for developing therapies for Shp2-associated diseases.
- Conditional mutation models provide insights into Shp2's dual role in development and disease.
Related Concept Videos
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

